Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-08-22
2006-08-22
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S420000, C514S410000
Reexamination Certificate
active
07094798
ABSTRACT:
This invention relates to pyrrolocarbazole derivatives according formula I wherein R1, R2, R7, R8, R9, X and Y are as defined in the specification wherein said derivatives specifically inhibit one or both of the checkpoint kinases Wee1 and Chk1
REFERENCES:
patent: 4912107 (1990-03-01), Kleinschroth et al.
patent: 5728709 (1998-03-01), Ikuina et al.
patent: 0 362 695 (1990-04-01), None
patent: 0 695 755 (1996-02-01), None
patent: WO 00/16781 (2000-03-01), None
patent: WO 01/85686 (2001-11-01), None
patent: WO 03/029482 (2003-04-01), None
Booth Richard John
Denny William Alexander
Dobrusin Ellen Myra
Kraker Alan
Lee Ho Huat
Coppins Janet L
Kershner David L.
Pfizer Inc
Saeed Kamal A.
Zelson Steve
LandOfFree
Inhibitors of checkpoint kinases (Wee1 and Chk1) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of checkpoint kinases (Wee1 and Chk1), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of checkpoint kinases (Wee1 and Chk1) will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3707514